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Abstract Nitrite, which is the major stable degradation product
of nitric oxide, exists in all tissues capable of nitric oxide
synthesis from L-arginine. The present study provides experi-
mental evidence that nitrite in contact with respiring mitochon-
dria accepts reducing equivalents from the ubiquinone cycle of
the respiratory chain. Univalent reduction of nitrite was totally
inhibited by myxothiazol. We therefore conclude on the
involvement of redox cycling that ubisemiquinone is associated
with the bc1 complex. Recycling of nitric oxide degradation
products via these electron carriers may become a threat to
energy-linked respiration since nitric oxide in direct contact with
mitochondria was shown to slow the energy-linked respiration
down and to trigger a mitochondrial source for superoxide
radicals. Until now, the existence of nitrite reductase activity was
only demonstrated in plants and bacteria. In addition, the present
observation elucidates the existence of a nitric oxide synthase-
independent nitric oxide source.
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1. Introduction
Nitric monoxide (NO, endothelium-derived relaxing factor)
exerts a great variety of physiological functions. Apart from
its regulation of the vascular tone, platelet aggregation and
leukocyte adhesion, NO was reported to play a role in cellular
signaling activities. NO is also involved in pathophysiological
processes such as in£ammation [1], cancer [2], ischemia [1,3]
and apoptosis [4]. NO is provided by various isoforms of
nitric oxide synthase (NOS) di¡ering in their tissue localiza-
tion.
The recent ¢ndings on the existence of a mitochondrial
NOS were considered as a physiological control system which
regulates energy-linked respiration [5]. However, NO levels
required to switch the physiological function of mitochondria
to pathophysiological activities are not provided by mitochon-
drial NOS, even under substrate saturation conditions. Patho-
physiological e¡ects of NO at the level of cell respiration
therefore require NOS-independent NO sources. Zweier et
al. have recently reported that nitrite (NO32 ), which is the
major breakdown product of NO in the heart, can be recycled
during ischemia [6^8]. Reducing equivalents, like pyridine nu-
cleotides, which accumulate in the reduced state, and low pH
values were supposed to be involved in nitrite recycling to NO
under ischemic conditions [8]. Pyridine nucleotides are co-en-
zymes of dehydrogenases which also form part of the mito-
chondrial respiratory chain. Electron carriers of the respira-
tory chain provide a wide span of redox potentials, many of
them are thermodynamically suited for nitrite reduction. Ni-
trite reduction to NO requires the interaction with a one
electron donor of the respiratory chain (NO3+2H+
e3CNO+H2O). It was earlier demonstrated that ischemia
a¡ects electron transfer of the respiratory chain such that
single electrons escape reducing oxygen to the superoxide rad-
ical. The most susceptible site of the mitochondrial redox
chain is the bifurcated transfer of two single electrons from
the ubiquinone pool to the bc1 complex. Nitrite reduction to
NO is therefore likely to occur under anaerobic conditions at
the same site involved in one electron reduction of dioxygen.
In the present study, we investigated whether or not electron
carriers of the respiratory chain may act as nitrite reductase.
2. Materials and methods
2.1. Chemicals
Rotenone, myxothiazol, antimycin A, thenoyltri£uoroacetone
(TTFA) were obtained from Sigma Chemical. Glutamic acid and ma-
lonic acid were received from Merck. Nitric monoxide gas was ob-
tained from AGA. Other chemicals were of analytical grade purity.
Hemoglobin (Hb) was prepared from bovine red blood cells as de-
scribed before [9].
2.2. Preparations of mitochondria and submitochondrial particles
Rat liver mitochondria (RLM) were prepared according to Szar-
kowska et al. [10] and stored in bu¡er containing 0.25 M sucrose, 20
mM triethanolamine, 1 mM EDTA (pH = 7.25) at 0‡C for 4^5 h.
Submitochondrial particles (SMP) were prepared from beef hearts
according to Graham et al. [11], kept at 34‡C in the same bu¡er
and thawed at the day of experiment. The concentrations of RLM
and SMP in the stock solutions were 50^60 and 36 mg protein/ml,
respectively. Before incubation, both SMP and RLM were diluted to a
concentration of 5 mg/ml with bu¡er containing additionally 10 mM
of potassium phosphate (pH = 7.25).
2.3. Experimental design
RLM (or SMP) alone or with di¡erent substrates was mixed with
Hb and inhibitors of the respiratory chain (total sample volume was
500 Wl) and kept under a £ow of argon for 10 min. Substitution of
oxygen by argon was facilitated using a shaking table to provide
gentle mixing of the mitochondrial suspension with argon. Then,
5 Wl of oxygen-free sodium nitrite (NaNO2) solution was injected
through a channel made in the experimental cell under anaerobic
conditions. Samples were aspirated by a syringe without exposure to
oxygen and kept for 2 h at room temperature (20 þ 2‡C) inside a
home-made anaerobic chamber. After 2 h, the samples were frozen
in liquid nitrogen and subjected to electron paramagnetic resonance
(EPR) measurements. The experimental medium contained 5 mg of
protein/ml RLM or SMP, 0.5 mM Hb, 5 mM succinate or 5 mM of
NADH or 2.5 mM glutamate plus 2.5 mM malate, 250 WM Hb, 50
WM NaNO2, 0.25 M sucrose, 20 mM triethanolamine, 1 mM EDTA
and 10 mM K2HPO4, pH = 7.25.
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2.4. EPR measurements
EPR spectra of RLM and SMP were recorded at the liquid nitrogen
temperature with a Bruker ER-200 SRP spectrometer in a quartz
dewar with a ¢nger under the following conditions: microwave fre-
quency 9.43 GHz, modulation frequency 100 kHz, microwave power
20 mW, modulation amplitude 5 G, gain 105. The double integral of
the signal was calculated and compared with that obtained from ni-
troso-heme complex standards. The preparation of nitroso-heme com-
plex standards was performed as described before [12]. For this pur-
pose, distilled water was deoxygenated by purging the water with
nitrogen exhaustively. The water was then bubbled with pure NO
gas for 20 min at 20 þ 2‡C. The concentration of NO in a saturated
solution was taken as 1.9 mM, according to the solubility of NO in
water [13]. The NO-saturated water was mixed with the oxygen-free
Hb solution (0.3 mM Hb in 100 mM phosphate bu¡er at pH = 6.0) to
obtain a concentration range of 0, 20 and 40 WM nitroso-heme com-
plex.
2.5. Statistics
Statistic parameters were calculated using Excell 5.0 (Microsoft).
3. Results
Addition of sodium nitrite to freshly isolated RLM under
anaerobic conditions resulted in the formation of NO as dem-
onstrated by the existence of the electron paramagnetic reso-
nance (EPR)-sensitive Hb-NO adduct (Fig. 1). The involve-
ment of electron carriers of the respiratory chain in the
reduction of nitrite to NO was concluded from the observa-
tion that SMP, containing all electron carriers but, in contrast
to intact mitochondria, lack endogenous substrates for respi-
ration, were inactive in nitrite reduction unless NADH or
succinate was added to start respiration. Complex I substrates
(glutamate/malate, NADH) as well as succinate (complex II
substrate), when used in the absence of mitochondria or sub-
mitochondrial particles, were rather ine¡ective in nitrite trans-
formation to NO (Fig. 2A and B). NO formation was not
observed when nitrate was used instead of nitrite (experiment
not shown).
Inhibition of the electron £ow from complex I into the ‘Q
cycle’ upon the addition of rotenone (see scheme in Fig. 3)
decreased NO generation from nitrite by 60% (Fig. 2A). Ac-
cordingly, when reducing equivalents were provided for the
respiratory chain from the succinate-dehydrogenase complex
(complex II), TTFA-induced in£ux inhibition slowed NO for-
mation down by 40% (Fig. 2B). The presence of rotenone in
this experiment excluded a reversed electron £ow to complex
I. Irrespectively of the substrate, supplying reducing equiva-
lents for respiration inhibition of the ‘Q cycle’ at the oxidant
site of the bc1 complex (using antimycin A) had no e¡ect on
NO recycling from nitrite. Total suppression (s 90%) of ni-
trite transformation to NO required the functional sequestra-
tion of the bc1 complex from the ‘Q cycle’ with myxothiazol.
4. Discussion
The scheme illustrates the £ow of reducing equivalents from
complex I and complex II substrates to the site of nitrite
reduction (Fig. 3). Glutamate plus malate, the couple used
to run electron £ow in intact mitochondria, provides
NADH for complex I via the citric acid cycle while succinate
supplies reducing equivalents directly to complex II after
being translocated into the matrix. In submitochondrial par-
ticles, NADH has a direct assess to complex I (Figs. 1 and 2).
Both electrons from complex I and from complex II are trans-
ferred through the ubiquinone pool to complex III where one
electron recycles through b-type cytochromes while the second
electron is linearily conducted to the terminal electron carrier
cytochrome oxidase. Rotenone, which inhibits the supply of
electrons from complex I, and TTFA, which inhibits electron
£ow from complex II, decrease the reduction of nitrite to NO
(Fig. 2). NO formation from nitrite was only observed as long
as electrons had access to the bc1 complex (complex III). Only
inhibition of the electron £ux to this part of the respiratory
chain prevented NO formation totally. The Rieske iron-sulfur
protein as well as cytochromes on the oxidant site of the
Rieske center can be excluded as potential reductants of ni-
Fig. 1. EPR spectra observed after 2 h of incubation of RLM or SMP with nitrite in the presence of deoxyHb and substrates for complex I or
complex II of the respiratory chain (succ = succinate, glu/mal = glutamate plus malate).
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trite since the strong positive redox potentials of these electron
carriers prevent an electron transfer on thermodynamic
grounds.
The present study provides experimental evidence on the
existence of a NOS-independent NO formation from the ma-
jor metabolic NO degradation product nitrite. In contrast to
all isoforms of NOS, which require L-arginine for NO syn-
thesis, the novel NOS-independent synthase system generates
NO from the stable degradation product of this bioregulator
synthesized elsewhere in the tissue. A direct reduction of ni-
trite to NO through reductants which normally accumulate
during ischemia was only of marginal signi¢cance (6 10%)
(see Fig. 2). Recycling of NO from nitrite requires respiring
mitochondria under conditions established during ischemia,
namely highly reduced electron carriers resulting from the
lack of oxygen. The use of adequate inhibitors of respiration
made it possible to localize the mitochondrial site of nitrite
reduction (see Fig. 3). It followed from these studies that
nitrite reductase activity can be attributed to the oxidant
site of ubiquinol at the cytochrome bc1 complex of the respi-
Fig. 2. Generation of NO-related EPR-sensitive Hb-NO adducts from nitrite in the presence of inhibitors preventing £ow of reducing equiva-
lents from complex I in the presence of TTFA (A) and from complex II in the presence of rotenone (B) (ROT = rotenone, MYX = myxothiazol,
AA = antimycin A).
Fig. 3. Schematic presentation of the in£ux and £ow of reducing equivalents through the various functionally complexes of the respiratory
chain. The bars indicate the sites of the various inhibitors used for the localization of the nitrite reductase activity.
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ratory chain (complex III) (Fig. 2). Similar to the single elec-
tron leak from the respiratory chain to dioxygen, antimycin A
was rather stimulating while myxothiazol totally abolished
nitrite reduction (Fig. 2). Myxothiazol inhibits the Q cycle
such that reduction of the bc1 complex from ubiquinol is
prevented. The site of myxothiazol interaction is assumed to
be the second electron transfer step from ubisemiquinone
(Fig. 3). Myxothiazol is likely to destabilize this semiquinone
species by an intervention on to its binding to the pocket of
the bc1 complex. We therefore believe that redox cycling semi-
quinones supply single electrons for nitrite reduction. It was
surprising that complex I or complex II, both exhibiting redox
potentials which are thermodynamically more appropriate for
nitrite reduction, do not interact with nitrite. This is not in
contradiction to the fact that inhibition of the complex I- or
complex II-mediated £ow of reducing equivalents into the Q
cycle did not result in a total inhibition of nitrite transforma-
tion to NO. It can be assumed that despite the presence of
complex I or complex II inhibitors, electrons do leak to the
site where nitrite is reduced. This assumption is based on the
fact that only myxothiazol, which deprives the Q cycle from
the electron supply of complex I or complex II, respectively,
totally suppresses nitrite reduction. Similarities with one elec-
tron reduction of nitrite suggest that the site which deviates
single electrons from the respiratory chain is identical both for
superoxide formation from oxygen and for NO formation
from nitrite. Our study provides evidence that the redox cou-
ple between ubiquinol and complex III can be used also for
cycling the NO oxidation product nitrite back to its bioactive
form. This may become a signi¢cant pathophysiological event
under conditions of stimulation of NO tissue levels during
ischemia or external administration of NO donors. NO recy-
cling from nitrite through mitochondria in that case may lead
to deleterious NO concentrations in mitochondria becoming
toxic through inhibition of energy-linked respiration at the
level of cytochrome oxidase, stimulation of superoxide radical
generation through inhibition of b-type cytochromes and ac-
tivation of Ca2-regulated metabolic pathways by the release
of Ca2 from mitochondria [14,15].
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